Adma Biologics Inc (NASDAQ:ADMA) currently has a daily average trading volume of 3.63M but it saw 3107895 shares traded in last market. With a market cap of 4.33B USD, the company’s current market price of $18.14 came rising about 1.45 while comparing to the previous closing price of $17.88. In past 52 weeks, the stock remained buoying in the range of price level as high as $25.67 and as low as $10.21. In the recent trading on the day, stock has struck highest price mark of $17.67 while lowest mark touched by it was $18.185.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Raymond James which resumed the stock as “Strong Buy” in its note to investors issued on July 19, 2023, recommending a price target of $5 for it. Raymond James issued its recommendations for the stock as it upgraded the price target for the stock is $5.
Over the week, ADMA’s stock price is moving 3.07% up while it is -11.21% when we observe its performance for the past one month. Year-to-date it is 62.25% up and over the past year, the stock is showing an upside performance of 5.77%.
The company is expected to be releasing its next quarterly report on 2025-May-07, for which analysts forecasted an EPS of 0.14 while estimate for next year EPS is 0.61. In next quarter, company is expected to be making quarterly sales of $128.8M as analysts are expecting the sales for current fiscal year at $507.67M and seeing the company making $638.56M in sales next year. Moreover, analysts are in estimates of $122.05M for current-quarter revenue.
Currently, Adma Biologics Inc’s total number of outstanding shares is 238.53M with 2.58% of that held by the insiders while 88.42% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 45.52% and return on equity (ROE) at 78.45%. It has a price to earnings ratio (P/E ratio) of 21.49 while having a 19.30 of forward P/E ratio. Stock’s beta reads 0.38. Stock has a price to book (P/B) ratio of 11.59 while price to sale or P/S ratio amounts to 9.43. Its return on asset (ROA) is 48.01% on average.
#
